---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-186437"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2025-08-22T23:59:59+00:00"
generated_at: "2026-05-17T10:31:31.871042+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lyra Therapeutics receives Nasdaq deficiency notice for equity below $2.5M minimum

## Summary
- Stockholders' equity as of June 30, 2025 was ~$1.6M, below the $2.5M continued listing requirement.
- Company has 45 calendar days (until October 4, 2025) to submit a plan to regain compliance to Nasdaq.
- If plan is accepted, Nasdaq may grant up to 180 additional calendar days to evidence compliance.
- Failure to regain compliance could lead to delisting; Company may appeal to a Nasdaq Hearings Panel.
- No immediate effect on listing or trading of common stock under symbol LYRA on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001193125-25-186437
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2025-08-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312525186437/0001193125-25-186437-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312525186437/d931635d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-186437
- JSON: https://secwatch.observer/filing/0001193125-25-186437.json
- Plain text: https://secwatch.observer/filing/0001193125-25-186437.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.